Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?

被引:6
|
作者
Kaplan, Huseyin [1 ]
Cengiz, Gizem [1 ]
Sas, Senem [1 ]
Eldemir, Yasemin Ozden [2 ]
机构
[1] Erciyes Univ, Fac Med, Dept Phys Med & Rehabil, Div Rheumatol, Kayseri, Turkiye
[2] Erciyes Univ, Fac Med, Dept Internal Med, Div Rheumatol, Kayseri, Turkiye
关键词
axial spondyloarthritis; disease activity; inflammation; psoriatic arthritis; rheumatoid arthritis; ANKYLOSING-SPONDYLITIS; LYMPHOCYTE RATIO; CLASSIFICATION CRITERIA; ACTIVITY SCORE-28; FIBRINOGEN RATIO; REMISSION; ASSOCIATION; ASDAS; CRP;
D O I
10.1007/s10067-023-06703-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To learn which of the simple inflammation markers obtained from routine laboratory tests showed active disease best. Methods The study included 256 patients (102 patients with axial spondyloarthritis [axSpA], 54 with psoriatic arthritis [PsA], and 100 with rheumatoid arthritis [RA]). The results of the routine laboratory tests requested during the outpatient clinic visits of the patients were noted. Inflammation-related ratio/indices were then calculated from these laboratory tests. Active and inactive diseases were defined according to the disease activity scores for each disease. Logistic regression and receiver operating characteristic (ROC) analyses were performed to determine the best laboratory marker(s) showing active disease and its cutoff value for all three diseases. Results C-reactive protein to albumin ratio (CAR) was significantly higher in patients with active axSpA, PsA, and RA diseases than those with inactive diseases ( p < 0.001, p = 0.006, and p < 0.001, respectively). In the logistic regression analysis, the CAR was the most important predictor of active disease in patients with axSpA, PsA, and RA. CAR had also showed the active disease at an acceptable level in axSpA and PsA and very well in RA. The cutoff values for active disease in axSpA, PsA, and RA were 0.75, 0.92, and 0.89, respectively. Conclusion CAR may be a promising simple laboratory marker to distinguish active disease in patients with axSpA, PsA, and RA. Key Points center dot Acute phase reactants and circulating blood cells have become an important target because of the search for a disease activity marker that can be used cheaply and quickly in the daily outpatient routine. center dot One or more of these simple markers have been previously discussed in various studies with different hypotheses. center dot We aimed to determine which of the inflammation markers obtained from routine laboratory tests showed active disease and to determine a cutoff value for this/these marker(s). center dot CAR was the most important simple laboratory marker to distinguish active disease in patients with axSpA, PsA, and RA. In addition, CAR showed the active disease at an acceptable level in axSpA and PsA, and very well in RA.
引用
收藏
页码:2959 / 2969
页数:11
相关论文
共 50 条
  • [1] Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
    Hüseyin Kaplan
    Gizem Cengiz
    Senem Şaş
    Yasemin Özden Eldemir
    Clinical Rheumatology, 2023, 42 : 2959 - 2969
  • [2] C-Reactive Protein-to-Albumin Ratio: A Novel Inflammatory Marker and Disease Activity Sign in Early Rheumatoid Arthritis
    Onder, Mustafa Erkut
    Orucoglu, Nurdan
    Omar, Firat
    Canataroglu, Abdullah
    AKTUELLE RHEUMATOLOGIE, 2022, 47 (03) : 239 - 247
  • [3] Role of the C-reactive Protein-to-Albumin Ratio in Assessing Disease Activity in Elderly Patients With Rheumatoid Arthritis
    Uslu, Sadettin
    Tasgoz, Filiz Cemre
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [4] C-reactive protein/albumin ratio and its improvement with disease activity among axial spondyloarthritis and psoriatic arthritis patients: A prospective study
    Abdelsalam, Noha A.
    Abdelhady, Enas I.
    Rabie, Mona
    Abd Elkhalek, Reham
    EGYPTIAN RHEUMATOLOGIST, 2024, 46 (04): : 180 - 184
  • [5] SERUM CALPROTECTIN AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS
    Jarlborg, Matthias
    Courvoisier, Delphine
    Lamacchia, Celine
    Martinez-Prat, Laura
    Bentow, Chelsea
    Mahler, Michael
    Finckh, Axel
    Gabay, Cem
    Nissen, Michael
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1588 - 1588
  • [6] USEFULNESS OF THE C-REACTIVE PROTEIN TO ALBUMIN RATIO IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
    Ardhaoui, M.
    Ghali, M.
    Mahbouba, J.
    Zrour, S.
    Bejia, I.
    Touzi, M.
    Bergaoui, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1308 - 1308
  • [7] Relationship between disease impact scores and C-reactive protein/albumin ratio in patients with psoriatic arthritis
    Duran, Tugba Izci
    Pamukcu, Melih
    CROATIAN MEDICAL JOURNAL, 2022, 63 (02) : 141 - 147
  • [8] C-REACTIVE PROTEIN TO ALBUMIN RATIO IS ASSOCIATED WITH DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
    Zhong, Z.
    Huang, Y.
    Huang, Q.
    Li, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1133 - 1134
  • [9] C-Reactive Protein-to-Albumin Ratio as a Prognostic Inflammatory Marker in COVID-19
    Celikkol, Aliye
    Guzel, Eda Celik
    Dogan, Mustafa
    Erdal, Berna
    Yilmaz, Ahsen
    JOURNAL OF LABORATORY PHYSICIANS, 2022,
  • [10] Clinical utility of C-reactive protein-to-albumin ratio in the management of patients with inflammatory bowel disease
    Nguyen, Anke L.
    Brick, Claudia
    Liu, David
    Gibson, David J.
    Gibson, Peter R.
    Sparrow, Miles P.
    JGH OPEN, 2024, 8 (04):